CTRI/2012/08/002922已完成3 期
A Phase III Clinical Trial to Study the Safety, Tolerability, and Immunogenicity of ZOSTAVAXâ?¢ in Healthy Adults in India
Merck Sharp and Dohme0 个研究点目标入组 250 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •A subject will be eligible to participate in this study if all of the following criteria apply:
- •a.Greater than or equal to 50 years of age.
- •b.Females have a negative pregnancy test and use an acceptable method of birth control, or are postmenopausal
- •c.Any underlying chronic illness must be in stable condition.
- •Note: We have entered maximum age of 99 yrs, as there is no upper limit defined in the study protocol, the same is approved by the directorate(DCGI).
排除标准
- •A subject will not be eligible to participate in this study if any of the following criteria apply:
- •a.History of hypersensitivity reaction to any vaccine component
- •b.Prior history of HZ
- •c.Previously received a varicella or zoster vaccine
- •d.Pregnant or breastfeeding
- •e.Have recently received blood products other than autologous blood transfusion
- •f.Use of immunosuppressive therapy
- •g.Known or suspected immune dysfunction
- •h.Use of nontopical antiviral therapy with activity against herpes virus
研究者
相似试验
进行中（未招募）
1 期
A clinical trial to assess the safety and efficacy of MK-1293 compared to Lantus? in treatment of Diabetes Mellitus.MedDRA version: 16.1Level: PTClassification code 10067584Term: Type 1 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersType 1 Diabetes MellitusEUCTR2011-003971-12-ESMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.500
进行中（未招募）
1 期
A Phase III Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (Oka/Merck) in Patients on Chronic/Maintenance Corticosteroids - Study of Zoster vaccine in subjects on chronic steroid maintenanceZoster VaccineMedDRA version: 8.1 Level: LLT Classification code 10019974 Term: Herpes zosterEUCTR2006-003651-20-GBMerck & Co Inc.,300
进行中（未招募）
不适用
A Phase III Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (Oka/Merck) in Patients on Chronic/Maintenance Corticosteroids - Study of Zoster vaccine in subjects on chronic steroid maintenanceZoster VaccineMedDRA version: 8.1Level: LLTClassification code 10019974Term: Herpes zosterEUCTR2006-003651-20-DEMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.300
进行中（未招募）
1 期
A Phase III Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (Oka/Merck) in Patients on Chronic/Maintenance CorticosteroidsEUCTR2006-003651-20-FRaboratoires Merck Sharp & Dohme - Chibret300
已完成
3 期
A Phase 3 Clinical Trial to evaluate the safety and efficacy of treatment with 2 mg intralesional Allovectin-7® compared to Dacarbazine (DTIC) or Temozolomide (TMZ) in subjects with recurrent metastatic melanomaNL-OMON31643Vical Incorporated15